RET-IN-10 is a potent inhibitor of RET. RET loss of function mutations leads to Hirschsprungs disease, while its gain of function mutations is associated with a variety of human tumors. RET-IN-10 has the potential for the research of cancer diseases (extracted from patent WO2021135938A1, compound 18)[1].
Molecular Weight:
536.65
CAS Number:
[2662622-44-6]
Formula:
C29H28N8OS
Target:
RET
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
